Medical cannabis: Another piece in the mosaic of autoimmunity?

Multiple Sclerosis (MS) Inflammatory Bowel Disease (IBD) Fibromyalgia

Key Findings

Currently, evidence supports cannabis and its active ingredients as immune-modulating agents, affecting T-cells, B-cells, monocytes, and microglia cells, causing an overall reduction in pro-inflammatory cytokine expression and an increase in anti-inflammatory cytokines. Several clinical trials in multiple sclerosis, inflammatory bowel disease, and fibromyalgia suggest cannabis' effectiveness as an immune-modulator.

Information and Links


Link: Medical cannabis: Another piece in the mosaic of autoimmunity?

Year: 2017

DOI: 10.1002/cpt.568


Ratings

(How Ratings Work)

Multiple Sclerosis (MS) — 3


Likely probability of the efficacy of cannabis for treatment of Multiple Sclerosis (MS) according to the results found in this study.

Inflammatory Bowel Disease (IBD) — 3


Likely probability of the efficacy of cannabis for treatment of Inflammatory Bowel Disease (IBD) according to the results found in this study.

Fibromyalgia — 3


Likely probability of the efficacy of cannabis for treatment of Fibromyalgia according to the results found in this study.

Drugs Used

Cannabis